Elite Pharmaceuticals Inc

1
OTCPK:ELTP (USA)  
$ 0.14 -0.00095 (-0.69%) 09:30 AM EST
On watch
10.46
P/B:
3.40
Market Cap:
$ 137.84M
Enterprise V:
$ 136.84M
Volume:
7.98K
Avg Vol (2M):
1.48M
Also Trade In:
Volume:
7.98K
Avg Vol (2M):
1.48M

Business Description

Description
Elite Pharmaceuticals Inc is a pharmaceutical company. It is principally engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology. The company's operating segment includes Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). It generates maximum revenue from the ANDA segment. The company focuses on developing pain management products; manufacturing a line of generic pharmaceutical products with approved Abbreviated New Drug Applications; developing additional generic pharmaceutical products; development of other products in its pipeline including the products with its partners; and commercialization of new products.
Name Current Vs Industry Vs History
Cash-To-Debt 1.13
Equity-to-Asset 0.64
Debt-to-Equity 0.17
Debt-to-EBITDA 2.59
Interest Coverage 5.98
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.73
Distress
Grey
Safe
Beneish M-Score 0.64
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 23.6
Name Current Vs Industry Vs History
5-Day RSI 45.16
9-Day RSI 48.95
14-Day RSI 52.88
6-1 Month Momentum % 258.48
12-1 Month Momentum % 243.9

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.82
Quick Ratio 1.02
Cash Ratio 0.45
Days Inventory 176.84
Days Sales Outstanding 52.61
Days Payable 37.83

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.5
Shareholder Yield % 0.27

Financials

ELTP's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:ELTP

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Elite Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 41.029
EPS (TTM) ($) 0.013
Beta -0.48
Volatility % 112.07
14-Day RSI 52.88
14-Day ATR ($) 0.012883
20-Day SMA ($) 0.138226
12-1 Month Momentum % 243.9
52-Week Range ($) 0.0269 - 0.17
Shares Outstanding (Mil) 1,013.92

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Elite Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Elite Pharmaceuticals Inc Stock Events

Event Date Price($)
No Event Data

Elite Pharmaceuticals Inc Frequently Asked Questions

What is Elite Pharmaceuticals Inc(ELTP)'s stock price today?
The current price of ELTP is $0.14. The 52 week high of ELTP is $0.17 and 52 week low is $0.03.
When is next earnings date of Elite Pharmaceuticals Inc(ELTP)?
The next earnings date of Elite Pharmaceuticals Inc(ELTP) is .
Does Elite Pharmaceuticals Inc(ELTP) pay dividends? If so, how much?
Elite Pharmaceuticals Inc(ELTP) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1